# BIK

## Overview
The BIK gene encodes the BCL2 interacting killer protein, a pro-apoptotic member of the Bcl-2 protein family, which is characterized by its BH3-only domain. This protein plays a pivotal role in the regulation of apoptosis, primarily by interacting with and neutralizing anti-apoptotic proteins such as Bcl-2 and Bcl-xL, thereby promoting cell death pathways (Spender2009TGFβ; Han1996Induction). BIK is predominantly localized to the endoplasmic reticulum and mitochondria, where it contributes to mitochondrial outer membrane permeabilization, a critical step in the apoptotic process (Mebratu2017Bik). The gene's expression is regulated by various factors, including p53 and E2F-1, and is notably induced by TGF-β signaling, which enhances apoptosis in specific cellular contexts (Spender2009TGFβ). Alterations in the BIK gene have been associated with several cancers, underscoring its significance in maintaining cellular homeostasis and its potential role as a tumor suppressor (Sturm2005Loss; Arena2003Mutations).

## Structure
The BIK protein, also known as BCL2 interacting killer, is a pro-apoptotic member of the BCL2 family, characterized by its BH3-only domain. The primary structure of BIK includes a BH3 domain, spanning amino acids 61-69, which is crucial for its apoptotic function by interacting with anti-apoptotic proteins (Arena2003Mutations). The secondary structure of BIK is predicted to be well-defined, unlike other BH3-only proteins that are largely unstructured. This structured conformation is similar to that of Bid, another BH3-only protein (Hinds2006Bim).

BIK is primarily localized to the endoplasmic reticulum (ER), where it contains a single transmembrane segment at its COOH terminus, integrating it into the ER membrane (Fu2007GRP78BiP). BIK's activity is regulated by phosphorylation, although the specific role of this post-translational modification in its apoptotic activity is not fully understood (Arena2003Mutations). BIK typically functions as a monomer and does not form a quaternary structure. Its interaction with other proteins, such as GRP78, can inhibit its pro-apoptotic function, highlighting its role in cellular apoptosis regulation (Fu2007GRP78BiP).

## Function
BIK (BCL2 interacting killer) is a pro-apoptotic member of the Bcl-2 protein family, primarily involved in promoting apoptosis in healthy human cells. It functions by interacting with and antagonizing anti-apoptotic proteins such as Bcl-2 and Bcl-xL, disrupting their ability to inhibit cell death pathways (Spender2009TGFβ; Han1996Induction). BIK is a BH3-only protein that localizes to the endoplasmic reticulum and mitochondria, where it plays a crucial role in mitochondrial outer membrane permeabilization. This process leads to the release of cytochrome c and the activation of the caspase cascade, ultimately resulting in apoptosis (Mebratu2017Bik; Han1996Induction).

In the context of B cells, BIK is involved in maintaining homeostasis by contributing to the default apoptotic state in the absence of survival stimuli. It is transcriptionally regulated by factors such as p53 and E2F-1, and its expression is induced by TGF-β signaling, which enhances apoptosis in centroblastic cells (Spender2009TGFβ). BIK's role in apoptosis is crucial for the elimination of unwanted B cells during immune responses, thereby maintaining B-cell homeostasis (Spender2009TGFβ).

## Clinical Significance
Mutations and alterations in the BIK gene have been implicated in various cancers, particularly B-cell lymphomas and renal cell carcinoma (RCC). In B-cell lymphomas, such as follicular lymphomas (FLs), marginal zone lymphomas (MZLs), and diffuse large B-cell lymphomas (DLBCLs), missense mutations in the BIK gene occur in 11% of FLs, 15% of MZLs, and 6% of DLBCLs. These mutations, along with sequence alterations in intronic regions, suggest a role in the pathogenesis of these cancers by potentially impairing BIK's proapoptotic function (Arena2003Mutations).

In RCC, the loss of BIK expression is a common feature, often due to gene deletion or transcriptional silencing through DNA methylation. This loss is associated with resistance to apoptosis, indicating BIK's role as a tumor suppressor in renal tissues (Sturm2005Loss).

BIK expression is also influenced by genetic variants, such as the SNP rs738276, which affects promoter activity and expression levels. This variant is linked to increased inflammation and a decline in lung function, particularly in smokers, highlighting BIK's role in inflammation-related diseases (Mebratu2024Bik).

## Interactions
BIK (BCL2 interacting killer) is a pro-apoptotic member of the Bcl-2 protein family that plays a significant role in apoptosis through its interactions with other proteins. BIK contains a BH3 domain, which is crucial for its interaction with anti-apoptotic proteins such as Bcl-2, Bcl-xL, and MCL-1. These interactions lead to the neutralization of the anti-apoptotic functions of these proteins, promoting apoptosis (Han1996Induction; Shimazu2007NBKBIK).

BIK interacts with Bcl-2 family members through its BH3 domain, similar to other pro-apoptotic proteins like Bax. This interaction is specific, as BIK does not directly interact with Bax or BAK but instead disrupts the interaction between BAK and MCL-1 or Bcl-xL, leading to BAK activation and apoptosis (Han1996Induction; Shimazu2007NBKBIK).

BIK is also involved in the regulation of apoptosis in response to various stimuli, such as estrogen deprivation and antiestrogen exposure in breast cancer cells, where its expression is significantly induced, leading to apoptotic cell death (Hur2004The). Additionally, BIK's role in apoptosis is highlighted in the context of protein synthesis inhibition, where it acts upstream of BAK to facilitate apoptosis (Shimazu2007NBKBIK).


## References


[1. (Arena2003Mutations) Vincenzo Arena, Maurizio Martini, Myriam Luongo, Arnaldo Capelli, and Luigi Maria Larocca. Mutations of the bik gene in human peripheral b‐cell lymphomas. Genes, Chromosomes and Cancer, 38(1):91–96, July 2003. URL: http://dx.doi.org/10.1002/gcc.10245, doi:10.1002/gcc.10245. This article has 45 citations.](https://doi.org/10.1002/gcc.10245)

[2. (Spender2009TGFβ) L C Spender, D I O’Brien, D Simpson, D Dutt, C D Gregory, M J Allday, L J Clark, and G J Inman. Tgf-β induces apoptosis in human b cells by transcriptional regulation of bik and bcl-xl. Cell Death &amp; Differentiation, 16(4):593–602, January 2009. URL: http://dx.doi.org/10.1038/cdd.2008.183, doi:10.1038/cdd.2008.183. This article has 68 citations.](https://doi.org/10.1038/cdd.2008.183)

[3. (Hinds2006Bim) M G Hinds, C Smits, R Fredericks-Short, J M Risk, M Bailey, D C S Huang, and C L Day. Bim, bad and bmf: intrinsically unstructured bh3-only proteins that undergo a localized conformational change upon binding to prosurvival bcl-2 targets. Cell Death &amp; Differentiation, 14(1):128–136, April 2006. URL: http://dx.doi.org/10.1038/sj.cdd.4401934, doi:10.1038/sj.cdd.4401934. This article has 177 citations.](https://doi.org/10.1038/sj.cdd.4401934)

[4. (Shimazu2007NBKBIK) Tsutomu Shimazu, Kurt Degenhardt, Alam Nur-E-Kamal, Junjie Zhang, Takeshi Yoshida, Yonglong Zhang, Robin Mathew, Eileen White, and Masayori Inouye. Nbk/bik antagonizes mcl-1 and bcl-xl and activates bak-mediated apoptosis in response to protein synthesis inhibition. Genes &amp; Development, 21(8):929–941, April 2007. URL: http://dx.doi.org/10.1101/gad.1522007, doi:10.1101/gad.1522007. This article has 115 citations.](https://doi.org/10.1101/gad.1522007)

[5. (Sturm2005Loss) I Sturm, C Stephan, B Gillissen, R Siebert, M Janz, S Radetzki, K Jung, S Loening, B Dörken, and P T Daniel. Loss of the tissue-specific proapoptotic bh3-only protein nbk/bik is a unifying feature of renal cell carcinoma. Cell Death &amp; Differentiation, 13(4):619–627, December 2005. URL: http://dx.doi.org/10.1038/sj.cdd.4401782, doi:10.1038/sj.cdd.4401782. This article has 83 citations.](https://doi.org/10.1038/sj.cdd.4401782)

[6. (Fu2007GRP78BiP) Yong Fu, Jianze Li, and Amy S. Lee. Grp78/bip inhibits endoplasmic reticulum bik and protects human breast cancer cells against estrogen starvation–induced apoptosis. Cancer Research, 67(8):3734–3740, April 2007. URL: http://dx.doi.org/10.1158/0008-5472.CAN-06-4594, doi:10.1158/0008-5472.can-06-4594. This article has 365 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-06-4594)

[7. (Han1996Induction) Jeonghoon Han, Peter Sabbatini, and Eileen White. Induction of apoptosis by human nbk/bik, a bh3-containing protein that interacts with e1b 19k. Molecular and Cellular Biology, 16(10):5857–5864, October 1996. URL: http://dx.doi.org/10.1128/mcb.16.10.5857, doi:10.1128/mcb.16.10.5857. This article has 155 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.16.10.5857)

[8. (Hur2004The) Jingyung Hur, Jessica Chesnes, Kathryn R. Coser, Roseanna S. Lee, Peter Geck, Kurt J. Isselbacher, and Toshi Shioda. The bik bh3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proceedings of the National Academy of Sciences, 101(8):2351–2356, February 2004. URL: http://dx.doi.org/10.1073/pnas.0307337101, doi:10.1073/pnas.0307337101. This article has 66 citations.](https://doi.org/10.1073/pnas.0307337101)

[9. (Mebratu2024Bik) Yohannes A. Mebratu, Jane T. Jones, Congjian Liu, Zerihun H. Negasi, Mizanur Rahman, Joselyn Rojas-Quintero, George T. O’Connor, Wei Gao, Josée Dupuis, Michael H. Cho, Augusto A. Litonjua, Scott Randell, and Yohannes Tesfaigzi. Bik promotes proteasomal degradation to control low-grade inflammation. Journal of Clinical Investigation, February 2024. URL: http://dx.doi.org/10.1172/jci170594, doi:10.1172/jci170594. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci170594)

[10. (Mebratu2017Bik) Yohannes A. Mebratu, Ivan Leyva-Baca, Marc G. Wathelet, Neal Lacey, Hitendra S. Chand, Augustine M. K. Choi, and Yohannes Tesfaigzi. Bik reduces hyperplastic cells by increasing bak and activating dapk1 to juxtapose er and mitochondria. Nature Communications, October 2017. URL: http://dx.doi.org/10.1038/s41467-017-00975-w, doi:10.1038/s41467-017-00975-w. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-00975-w)